Skip to main content
Clinical Trials/NCT05859061
NCT05859061
Completed
N/A

Intraoperative Cryoanalgesia for Pain Management After Sternotomy: A Randomized Pilot Trial

Northwestern University1 site in 1 country32 target enrollmentApril 10, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pain, Postoperative
Sponsor
Northwestern University
Enrollment
32
Locations
1
Primary Endpoint
Average Daily Opioid Consumption in MME
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

This study will investigate the feasibility of cryoanalgesia in patients undergoing cardiac surgery via a median sternotomy. Cryoanalgesia is a technique that uses extremely cold temperatures to temporarily ablate nerves and block pain signals. Cryoanalgesia has been used for decades for pain control after thoracic surgery and has been associated with decreased opioid consumption, decreased pain scores, and shorter hospital stays. The results of this study may lead to a useful alternative for pain control in cardiac surgery patients.

Registry
clinicaltrials.gov
Start Date
April 10, 2023
End Date
February 13, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sawyer Naze

Assistant Professor of Anesthesiology

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • Scheduled for elective CABG (coronary artery bypass graft) or single valve surgery via median sternotomy
  • Reasonable expectation to be extubated within 24 hours postop

Exclusion Criteria

  • Prior history of surgery to the thorax (sternotomy, thoracotomy, thoracoscopy)
  • Hemisternotomy approach
  • History of cold urticaria, cryoglobulinemia, Raynaud's disease, or diabetic neuropathy
  • Preoperative use of opioids
  • History of chronic pain or associated syndromes
  • Concurrent Cox maze procedure
  • Need for post-bypass mechanical circulatory support (ECMO, IABP) or open chest
  • Women who are pregnant or breastfeeding
  • Patients who are unable to consent for themselves

Outcomes

Primary Outcomes

Average Daily Opioid Consumption in MME

Time Frame: 48 hours

The average daily opioid consumption in morphine milligram equivalents (MME) during the first 48 hours postoperatively serves as the study's primary outcome.

Secondary Outcomes

  • Quality of Recovery Score(48 hours/POD2 (post-operative day 2), 10 days +/- 4 days, 90 days +/- 14 days, & 180 days +/- 30 days)
  • Patient Satisfaction with Pain Control Regimen(24 hours/POD1 (post-operative day 1), 48 hours/POD2, 10 days +/- 4 days, 90 days +/- 14 days, & 180 days +/- 30 days)
  • Pain Severity(24 hours/POD1 (post-operative day 1), 48 hours/POD2, 10 days +/- 4 days, 90 days +/- 14 days, & 180 days +/- 30 days)
  • Pain Quality(24 hours/POD1 (post-operative day 1), 48 hours/POD2, 10 days +/- 4 days, 90 days +/- 14 days, & 180 days +/- 30 days)
  • Average Daily Pain Scores(during the first 48 hours postoperatively (starting upon ICU arrival))

Study Sites (1)

Loading locations...

Similar Trials